JAGSNPHARMPharmaceuticals
Jagsonpal Pharmaceuticals Ltd — Balance Sheet
₹184.03
+0.05%
Jagsonpal Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 6.64 Cr | 6.61 Cr | 6.55 Cr | 6.55 Cr | — |
| Share Issued | 6.64 Cr | 6.61 Cr | 6.55 Cr | 6.55 Cr | — |
| Total Debt | 9.24 Cr | 8.94 Cr | 6.00 Cr | 0.00 | — |
| Tangible Book Value | 154.33 Cr | 187.40 Cr | 158.89 Cr | 132.73 Cr | — |
| Invested Capital | 239.95 Cr | 187.40 Cr | 158.89 Cr | 132.76 Cr | — |
| Working Capital | 135.29 Cr | 180.13 Cr | 136.99 Cr | 82.11 Cr | — |
| Net Tangible Assets | 154.33 Cr | 187.40 Cr | 158.89 Cr | 132.73 Cr | — |
| Capital Lease Obligations | 9.24 Cr | 8.94 Cr | 6.00 Cr | 0.00 | — |
| Common Stock Equity | 239.95 Cr | 187.40 Cr | 158.89 Cr | 132.76 Cr | — |
| Total Capitalization | 239.95 Cr | 187.40 Cr | 158.89 Cr | 132.76 Cr | — |
| Total Equity Gross Minority Interest | 239.95 Cr | 187.40 Cr | 158.89 Cr | 132.76 Cr | — |
| Stockholders Equity | 239.95 Cr | 187.40 Cr | 158.89 Cr | 132.76 Cr | — |
| Other Equity Interest | 226.67 Cr | 17.07 Cr | 8.77 Cr | 117.76 Cr | — |
| Capital Stock | 13.28 Cr | 13.22 Cr | 13.10 Cr | 13.10 Cr | — |
| Common Stock | 13.28 Cr | 13.22 Cr | 13.10 Cr | 13.10 Cr | — |
| Total Liabilities Net Minority Interest | 38.31 Cr | 29.68 Cr | 36.06 Cr | 31.47 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 12.41 Cr | 10.55 Cr | 8.48 Cr | 4.49 Cr | — |
| Non Current Deferred Taxes Liabilities | 3.07 Cr | 2.07 Cr | 2.16 Cr | 3.24 Cr | — |
| Long Term Debt And Capital Lease Obligation | 7.63 Cr | 7.56 Cr | 5.25 Cr | 0.00 | — |
| Long Term Capital Lease Obligation | 7.63 Cr | 7.56 Cr | 5.25 Cr | 0.00 | — |
| Long Term Provisions | 0.67 Cr | 0.92 Cr | 1.07 Cr | 1.26 Cr | — |
| Current Liabilities | 25.90 Cr | 19.13 Cr | 27.57 Cr | 26.97 Cr | — |
| Other Current Liabilities | 3.20 Cr | 0.10 Cr | 0.14 Cr | 0.02 Cr | — |
| Current Debt And Capital Lease Obligation | 1.61 Cr | 1.38 Cr | 0.75 Cr | 0.00 | — |
| Current Capital Lease Obligation | 1.61 Cr | 1.38 Cr | 0.75 Cr | 0.00 | — |
| Current Provisions | 1.01 Cr | 0.75 Cr | 0.38 Cr | 0.49 Cr | — |
| Payables | 9.73 Cr | 15.09 Cr | 25.11 Cr | 26.28 Cr | — |
| Accounts Payable | 9.73 Cr | 7.60 Cr | 16.58 Cr | 18.55 Cr | — |
| Total Assets | 278.26 Cr | 217.08 Cr | 194.95 Cr | 164.22 Cr | — |
| Total Non Current Assets | 117.07 Cr | 17.82 Cr | 30.39 Cr | 55.14 Cr | — |
| Other Non Current Assets | 4.42 Cr | 2.11 Cr | 2.03 Cr | 2.92 Cr | — |
| Investmentin Financial Assets | 17.39 Cr | 4.70 Cr | 3.38 Cr | 29.05 Cr | — |
| Available For Sale Securities | 17.39 Cr | 4.70 Cr | 3.38 Cr | 20.17 Cr | — |
| Goodwill And Other Intangible Assets | 85.62 Cr | — | 0.00 | 0.03 Cr | 0.03 Cr |
| Other Intangible Assets | 75.92 Cr | — | — | 2.35 Cr | 2.35 Cr |
| Goodwill | 9.69 Cr | — | 0.00 | 0.03 Cr | 0.03 Cr |
| Net PPE | 8.84 Cr | 9.30 Cr | 24.28 Cr | 22.57 Cr | — |
| Gross PPE | 8.84 Cr | 10.43 Cr | 32.87 Cr | 58.10 Cr | — |
| Other Properties | 8.84 Cr | 8.39 Cr | 5.93 Cr | 22.37 Cr | — |
| Current Assets | 161.19 Cr | 199.25 Cr | 164.56 Cr | 109.08 Cr | — |
| Other Current Assets | 4.02 Cr | 8.08 Cr | 8.07 Cr | -81000.00 | — |
| Assets Held For Sale Current | 0.00 | 17.18 Cr | 0.00 | — | — |
| Inventory | 15.20 Cr | 15.00 Cr | 20.68 Cr | 29.74 Cr | — |
| Accounts Receivable | 13.18 Cr | 10.95 Cr | 20.87 Cr | 15.58 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 128.80 Cr | 147.93 Cr | 114.71 Cr | 47.40 Cr | — |
| Other Short Term Investments | 117.58 Cr | 135.17 Cr | 103.66 Cr | 24.88 Cr | — |
| Cash And Cash Equivalents | 11.21 Cr | 12.76 Cr | 11.05 Cr | 22.53 Cr | — |
| Retained Earnings | — | 104.19 Cr | 94.54 Cr | 69.37 Cr | 58.59 Cr |
| Additional Paid In Capital | — | 11.12 Cr | 0.60 Cr | 0.60 Cr | 0.60 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.92 Cr | 1.07 Cr | 1.26 Cr | 0.02 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.75 Cr | 0.38 Cr | 0.49 Cr | 0.85 Cr |
| Other Payable | — | 7.42 Cr | 8.51 Cr | 7.50 Cr | 2.08 Cr |
| Dividends Payable | — | 0.08 Cr | 0.00 | 0.00 | 2.62 Cr |
| Total Tax Payable | — | 0.00 | 0.02 Cr | 0.23 Cr | 0.45 Cr |
| Defined Pension Benefit | — | 2.11 Cr | 2.03 Cr | 2.42 Cr | 0.00 |
| Non Current Prepaid Assets | — | 0.47 Cr | 0.38 Cr | 0.00 | 5.02 Cr |
| Accumulated Depreciation | — | -1.13 Cr | -8.59 Cr | -35.53 Cr | -34.40 Cr |
| Machinery Furniture Equipment | — | 2.04 Cr | 1.80 Cr | 32.96 Cr | 32.90 Cr |
| Buildings And Improvements | — | 0.00 | 16.38 Cr | 16.38 Cr | 16.09 Cr |
| Land And Improvements | — | 0.00 | 8.76 Cr | 8.76 Cr | 8.76 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 8.19 Cr | 8.30 Cr | 16.36 Cr | 14.34 Cr |
| Finished Goods | — | 7.71 Cr | 11.79 Cr | 14.47 Cr | 10.31 Cr |
| Work In Process | — | 1.26 Cr | 1.08 Cr | 2.70 Cr | 12.47 Cr |
| Raw Materials | — | 6.02 Cr | 7.81 Cr | 12.57 Cr | 6.94 Cr |
| Allowance For Doubtful Accounts Receivable | — | -1.05 Cr | -0.60 Cr | -0.48 Cr | -0.43 Cr |
| Gross Accounts Receivable | — | 12.00 Cr | 21.47 Cr | 16.05 Cr | 13.10 Cr |
| Cash Equivalents | — | 7.01 Cr | 0.00 | 2.80 Cr | 49.18 Cr |
| Cash Financial | — | 5.75 Cr | 11.05 Cr | 22.53 Cr | 9.45 Cr |
| Current Debt | — | — | 0.00 | 0.00 | 6.79 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | — | 0.00 | 8.89 Cr | 1.02 Cr |
| Fixed Assets Revaluation Reserve | — | — | — | 7.84 Cr | 7.84 Cr |
| Long Term Debt | — | — | — | 0.00 | 0.00 |
| Current Deferred Taxes Liabilities | — | — | — | 7.96 Cr | 3.82 Cr |
| Non Current Deferred Taxes Assets | — | — | — | 0.00 | 0.00 |
| Held To Maturity Securities | — | — | — | 1.02 Cr | 1.02 Cr |
| Construction In Progress | — | — | — | 0.00 | 0.00 |
| Hedging Assets Current | — | — | — | 0.00 | 0.00 |
| Current Deferred Assets | — | — | — | 0.00 | 0.00 |
| Restricted Cash | — | — | — | 0.89 Cr | 0.31 Cr |
| Other Receivables | — | — | — | 0.14 Cr | 1.54 Cr |
| Trading Securities | — | — | — | — | 11.06 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Jagsonpal Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.